http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34074212

Outgoing Links

Predicate Object
contentType Case Reports|Journal Article|Research Support, N.I.H., Extramural
endingPage 153
issn 1432-0533
0001-6322
issueIdentifier 1
pageRange 143-153
publicationName Acta Neuropathologica
startingPage 143
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bafeebee97d8456c1df9d87cb063080a
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_69731bb36a4061fbaf74a48f03dfbd8c
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_00e31edf678229ce71e59281d93a4e66
bibliographicCitation Plowey ED, Bussiere T, Rajagovindan R, Sebalusky J, Hamann S, von Hehn C, Castrillo-Viguera C, Sandrock A, Budd Haeberlein S, van Dyck CH, Huttner A. Alzheimer disease neuropathology in a patient previously treated with aducanumab. Acta Neuropathologica. 2022 May 17;144(1):143–53. doi: 10.1007/s00401-022-02433-4.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dfe4cc2ae5a51011e77897734c77c49e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c7b04bd9d60a0060fefc18bf1382454d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7efffe027ee854f5a7c482f63633982
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3fcbdb87ab7dd965ef849684124afce6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9016-4751
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae63bbb799d153e51e001a0b2ee2fe3f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad8df107f523c151181bb771ad9a59a1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac56fdd5880de9ad40ffa4de27a9f727
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d28ec6dff5a818fad8d3f2efb9004df9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0466a5948db41464d202a2f88a8a7c7a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92313ea5c81d27964a66dbd4e5a04c78
date 2022-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1007/s00401-022-02433-4
https://pubmed.ncbi.nlm.nih.gov/PMC9217863
https://pubmed.ncbi.nlm.nih.gov/35581440
isPartOf https://portal.issn.org/resource/ISSN/1432-0533
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/133
https://portal.issn.org/resource/ISSN/0001-6322
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title Alzheimer disease neuropathology in a patient previously treated with aducanumab
discusses http://id.nlm.nih.gov/mesh/M0556300
http://id.nlm.nih.gov/mesh/M0001047
http://id.nlm.nih.gov/mesh/M0024786
http://id.nlm.nih.gov/mesh/M000608738
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8d05c5ff041dba232d911c48d686a255
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8642d21b3cea0778947b7ceb6a1487e3
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7404
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11262
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852

Total number of triples: 46.